Current insights in renal cell cancer pathology

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 3, 2008, Pages 225-238

  Mancini, Vito ^a   Battaglia, Michele ^a   Ditonno, Pasquale ^a   Palazzo, Silvano ^a   Lastilla, Gaetano ^a   Montironi, Rodolfo ^b   Bettocchi, Carlo ^a   Cavalcanti, Elisabetta ^a   Ranieri, Elena ^c   Selvaggi, Francesco P ^a  

^a UNIVERSITY OF BARI   (Italy)

^b University of the Marche Region   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Kidney neoplasm; Pathological diagnosis; Prognosis; Renal cell cancer; Targeted therapy

Indexed keywords

CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; CYSTADENOMA; EARLY CANCER; GENE FUSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY COLLECTING DUCT CARCINOMA; KIDNEY MEDULLARY CARCINOMA; KIDNEY SARCOMATOID TUMOR; LYMPH NODE METASTASIS; MULTILOCULAR CYSTIC KIDNEY CELL CARCINOMA; NEUROBLASTOMA; ONCOCYTOMA; PAPILLARY KIDNEY CELL CARCINOMA; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TISSUE MICROARRAY; TUMOR NECROSIS; TUMOR VOLUME;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; PROGNOSIS; PROTEIN TRANSPORT;

EID: 42949110736     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.05.017     Document Type: Review

References (66)

1. International Agency for Research on Cancer (IARC) Cancer Databases, World Health Organization. www-dep.iarc.fr Accessed December 15, 2006
2. Delahunt B., and Eble J.N. Board of Education of the Royal College of Pathologists of Australasia. Renal cell neoplasia. Pathology 34 (2002) 13-20
3. Nagashima Y., Inayama Y., Kato Y., et al. Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date. Pathol Int 54 (2004) 377-386
4. Mostofi F.K., Sesterhenn I.A., Sobin L.H., et al. Histological typing of kidney tumors. Geneva World Health Organization 25 (1981) 1-23
5. Polascik T.J., Bostwick D.G., and Cairns P. Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 60 (2002) 941-946
6. Velickovic M., Delahunt B., and Grebe S.K. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus. Cancer Res 59 (1999) 1323-1326
7. Gunawan B., Huber W., Holtrup M., et al. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: Gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res 61 (2001) 7731-7738
8. Kopper L., and Timar J. Genomics of renal cell cancer-Does it provide breakthrough?. Pathol Oncol Res 12 (2006) 5-11
9. Yao M., Yoshida M., Kishida T., et al. VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma. J Natl Cancer Inst 94 (2002) 1569-1575
10. Sobin L.H., and Fleming I.D. TNM Classification of Malignant Tumors, fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80 (1997) 1803-1804
11. Eble J.N., and Bonsib S.M. Extensively cystic renal neoplasms: Cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 15 (1998) 2-20
12. Delahunt B., and Eble J.N. History of the development of the classification of renal cell neoplasia. Clin Lab Med 25 (2005) 231-246
13. Kovacs G., Wilkens L., Papp T., et al. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst 81 (1989) 527-530
14. Zbar B., Tory K., Merino M., et al. Hereditary papillary renal cell carcinoma. J Urol 151 (1994) 561-566
15. Renshaw A.A., Granter S.R., Fletcher J.A., et al. Renal cell carcinomas in children and young adults: Increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol 23 (1999) 795-802
16. Delahunt B., Eble J.N., McCredie M.R., et al. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32 (2001) 590-595
17. Amin M.B., Corless C.L., Renshaw A.A., et al. Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 21 (1997) 621-635
18. Tickoo S.K., Lee M.W., Eble J.N., et al. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol 24 (2000) 1247-1256
19. Young A.N., Amin M.B., Moreno C.S., et al. Expression profiling of renal epithelial neoplasms: A method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 158 (2001) 1639-1651
20. van den Berg E., and Dijkhuizen T. Classification of renal cell cancer based on (cyto)genetic analysis. Contrib Nephrol 128 (1999) 51-61
21. Brunelli M., Eble J.N., Zhang S., et al. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Pathol 18 (2005) 61-69
22. Bugert P., Gaul C., Weber K., et al. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 76 (1997) 203-208
23. Nickerson M.L., Warren M.B., Toro J.R., et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 3 (2002) 157-164
24. Castillo M., Petit A., Mellado B., et al. C-kit expression in sarcomatoid renal cell carcinoma: Potential therapy with imatinib. J Urol 171 (2004) 2176-2180
25. Cavazzana A.O., Prayer-Galetti T., Tirabosco R., et al. Bellini duct carcinoma. A clinical and in vitro study. Eur Urol 30 (1996) 340-344
26. Schoenberg M., Caims P., Brooks J.D., et al. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Genes Chromosomes Cancer 12 (1995) 76-80
27. Fuzesi L., Cober M., and Mittermayer C. Collecting duct carcinoma: Cytogenetic characterization. Histopathology 21 (1992) 155-160
28. Antonelli A., Portesi E., Cozzoli A., et al. The collecting duct carcinoma of the kidney: A cytogenetical study. Eur Urol 43 (2003) 680-685
29. Khan A., Thomas N., Costello B., et al. Renal medullary carcinoma: Sonographic, computed tomography, magnetic resonance, and angiographic findings. Eur J Radiol 35 (2000) 1-7
30. Argani P., Antonescu C.R., Couturier J., et al. PRCCTFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 26 (2002) 1553-1566
31. Argani P., Antonescu C.R., Illei P.B., et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159 (2001) 179-192
32. Clark J., Lu Y.J., Sidhar S.K., et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15 (1997) 2233-2239
33. Eble J.N., Epstein J.I., and Sesterrhenn I.A. Pathology and genetics. Tumors of the urinary system and male genital organs (2004), IARC Press, Lyon p. 12-78.
34. Cangiano T., Liao J., Naitoh J., et al. Sarcomatoid renal cell carcinoma: Biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol 17 (1999) 523
35. Hou L.T., and Willis R.A. Renal carcino-sarcoma, true and false. J Pathol Bacteriol 85 (1963) 139-144
36. Juhasz J., Sebok J., Galambos J., et al. Renal carcinosarcoma (mixed tumours) of the kidney. Int Urol Nephrol 12 (1980) 103-108
37. Farrow Jr. G.M., Harrison E.G., and Utz D.C. Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. Cancer 22 (1968) 556-563
38. de Peralta-Venturina M., Moch H., Amin M., et al. Sarcomatoid differentiation in renal cell carcinoma: A study of 101 cases. Am J Surg Pathol 25 (2001) 275-284
39. Mian B.M., Bhadkamkar N., Slaton J.W., et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 167 (2002) 65-70
40. Dall'Oglio M.F., Lieberknecht M., Gouveia V., et al. Sarcomatoid differentiation in renal cell carcinoma: Prognostic implications. Int Braz J Urol 31 (2005) 10-16
41. Jones T.D., Eble J.N., Wang M., et al. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer 104 (2005) 1195-1203
42. Kuroiwa K., Kinoshita Y., Shiratsuchi H., et al. Renal cell carcinoma with rhabdoid features: An aggressive neoplasm. Histopathology 41 (2002) 538-548
43. Henke R.P., and Erbersdobler A. Numerical chromosomal aberrations in papillary renal cortical tumors: Relationship with histopathological features. Virchows Arch 440 (2002) 604-609
44. Perez-Ordonez B., Hamed G., Campbell S., et al. Renal Oncocytoma: A clinicopathologic study of 70 cases. Am J Surg Pathol 21 (1997) 871-883
45. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumors. 6th ed. (2002), John Wiley and Sons, New York
46. Delahunt B., Kittelson J.M., McCredie M.R., et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: Assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 94 (2002) 658-664
47. Han K.R., Bui M.H., Pantuck A.J., et al. TNM T3a renal cell carcinoma: Adrenal gland involvement is not the same as renal fat invasion. J Urol 169 (2003) 899-903
48. Thompson R.H., Leibovich B.C., Cheville J.C., et al. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?. J Urol 173 (2005) 918-921
49. Thompson R.H., Leibovich B.C., Cheville J.C., et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?. J Urol 174 (2005) 1218-1221
50. Karakiewicz P.I., Lewinshtein D.J., Chun F.K., et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol 50 (2006) 521-529
51. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 653-663
52. Ficarra V., Righetti R., Martignoni G., et al. Prognostic value of renal cell carcinoma nuclear grading: Multivariate analysis of 333 cases. Urol Int 67 (2001) 130-134
53. Fiori E., De Cesare A., Galati G., et al. Prognostic significance of primary-tumor extension, stage, and grade of nuclear differentiation in patients with renal cell carcinoma. J Exp Clin Cancer Res 21 (2002) 229-232 655-63.
54. Lohse C.M., Blute M.L., Zincke H., et al. Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2042 patients. Am J Clin Pathol 118 (2002) 877-886
55. Gudbjartsson T., Hardarson S., Petursdottir V., et al. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: A retrospective nation-wide study of 629 patients. Eur Urol 48 (2005) 593-600
56. Lopez-Beltran A., Scarpelli M., Montironi R., et al. 2004 WHO classification of renal tumors of the adults. Eur Urol 49 (2006) 798-805
57. Leibovitch I., Lev R., Mor Y., et al. Extensive necrosis in renal cell carcinoma specimens: Potential clinical and prognostic implications. Isr Med Assoc J 3 (2001) 563-565
58. Lang H., Lindner V., Letourneux H., et al. Prognostic value of microscopic venous invasion in renal cell carcinoma: Long-term follow-up. Eur Urol 46 (2004) 331-335
59. Giuliani L., Giberti C., Martorana G., et al. Radical extensive surgery for renal cell carcinoma: Long-term results and prognostic factors. J Urol 143 (1990) 468-474
60. Minervini A., Lilas L., Morelli G., et al. Regional lymph node dissection in the treatment of renal cell carcinoma: Is it useful in patients with no suspected adenopathy before or during surgery?. BJU Int 88 (2001) 169-172
61. Sobin L.H., Wittekind C.H., and International Union Against Cancer (UICC). TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss Publications, New York
62. Joslyn S.A., Sirintrapun S.J., and Konety B.R. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: Retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Urology 65 (2005) 675-680
63. Pantuck A.J., Zisman A., Dorey F., et al. Renal cell carcinoma with retroperitoneal lymph nodes: Role of lymph node dissection. J Urol 169 (2003) 2076-2083
64. Pantuck A.J., Zisman A., Dorey F., et al. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy. Cancer 97 (2003) 2995-3002
65. Blom J.H., van Poppel H., Marechal J.M., et al. Radical nephrectomy with and without lymph node dissection: Preliminary results of EORTC randomized Phase III protocol 30881. EORTC Genitourinary Group. Eur Urol 36 (1999) 570-575
66. Terrone C., Cracco C., Porpiglia F., et al. Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol 49 (2006) 324-331